Lineage Foundation for Good Celebrates One-Year Anniversary, Announces “Holidays for Good” Campaign
16.11.2022 16:00:00 EET | Business Wire | Press release
Lineage Foundation for Good (the “Foundation”), the independent philanthropic arm of Lineage Logistics, LLC (“Lineage”), recently celebrated its one-year anniversary. The nonprofit, which aims to redirect food that would otherwise go to waste and address hunger to support the social and economic mobility of our communities, has successfully donated the equivalent of 239 million meals over the past two years.
“Given recent events, global hunger and food insecurity is rising, affecting more than 800 million people,” said Christine Rees-Zecha, Board President of the Lineage Foundation for Good. “Through the Lineage Foundation for Good, we aim to leverage our network, expertise, and partnerships to prevent waste and redirect food into the communities that need it most. While there is still more work to do, I am proud of the accomplishments we achieved in the first year, including delivering more than 200 million meals to those in need, made possible by our dedicated team members.”
Last October, Lineage launched the Lineage Foundation for Good following the Company’s successful inaugural campaign, which provided 100 million meals to people in need during the height of the pandemic. In addition to supporting Lineage’s philanthropic efforts, the Foundation has sought to strengthen initiatives and organizations that align with the Company’s mission to create innovative and sustainable solutions to help reduce food waste and fight food insecurity.
At its inception, the Foundation set a goal to donate the equivalent of 500 million meals to people in need by 2025. To date, it is on track to significantly exceed this goal. As the Foundation continues to make progress on this commitment, it has also achieved notable progress in the following areas:
- Raised over $234,000 to support the Global FoodBanking Network and the Polish Humanitarian Action Organization’s efforts in response to the ongoing conflict in Ukraine.
- Supported Lineage team members and their families impacted by the conflict who returned to Ukraine to assist by continuing to pay their wages, as well as providing stipends to team members who are housing refugees and covered the relocation costs of five families.
- Contributed over 1,000 volunteer hours in communities worldwide, such as volunteering at food banks and distributing meals at community-based kitchens.
- Issued more than $1.6 million in community-based grants to local food banks, schools and other community-based organizations to help with operational costs.
- Donated over $600,000 to the Team Member Hardship Grant program, an initiative dedicated to financially supporting Lineage team members through times of hardship.
- In partnership with Penske, Darden Foundation, supported the donation of 10 refrigerated trucks to Feeding America® member food banks.
- Received a historic one-million-pound donation that will benefit six food banks within the Feeding America network.
- Grew its global network of partnerships to 50 strategic partners, which includes the Global FoodBanking Network, Feeding America, Empowerment Plan, Move for Hunger and the Darden Foundation. Through these partnerships, the Foundation has coordinated volunteer events and made charitable donations to partners.
“Over the past year, we’ve partnered with the Lineage Foundation for Good on their mission to reduce food waste and address food insecurity,” said Diane Letson, vice president of food industry partnerships at Feeding America. “With nearly 34 million people facing hunger in America, and amid the challenging inflationary environment many are experiencing, we are grateful for the recent work that Lineage and its partners accomplished in diverting one million pounds of food from going to waste and ensuring that it reached our neighbors in need.”
Building on the momentum of a successful first year, the Foundation is also launching the “Holidays for Good” Campaign to donate food to local communities during the holiday season. Beginning in November and running through the holiday season, “Holidays for Good” will contribute the equivalent of one million meals through customer product donations, food drives and volunteer events that benefit local community food banks.
For more information on the Lineage Foundation for Good, visit the Foundation page here. You can also reach out to foundation@lineagelogistics.com for information on partnership opportunities, volunteer events, and other ways to support.
About Lineage Foundation for Good
The Lineage Foundation for Good (the “Foundation”) is the independent philanthropic arm of Lineage Logistics, LLC (“Lineage”). The Foundation leverages the unique access, influence, experience, and expertise of Lineage, one of the world’s largest temperature-controlled logistics solutions providers, and its customers and partners to reduce food waste and fight food insecurity – a need that was accelerated by the practical challenges of getting quality food to those in need during the COVID-19 pandemic. Central to the Foundation’s mission is to develop a dynamic, real-time, and global link between those who commercially produce our food and the individuals, families, and communities who need it most. The Foundation creates a system in which food products, including those that might have otherwise gone to waste, can be quickly and easily steered to food pantries and other non-profits combatting food insecurity around the world. The Foundation supports various philanthropic initiatives that have an impact in the communities in which we live and work, and is proud to partner with Feeding America, the Global FoodBanking Network, and other organizations to expand its reach, maximize its impact, and help feed the world.
About Lineage Logistics
Lineage Logistics is the world’s largest temperature-controlled industrial REIT and logistics solutions provider. It has a global network of over 400 strategically located facilities totaling over 2 billion cubic feet of capacity, which spans 20 countries across North America, Europe, and Asia-Pacific. Lineage’s industry-leading expertise in end-to-end logistical solutions, its unrivaled real estate network and the development and deployment of innovative technology help increase distribution efficiency, advance sustainability, minimize supply chain waste, and, most importantly, as a Visionary Partner of Feeding America, help feed the world. In recognition of the company’s leading innovations and sustainability initiatives, Lineage was a 2022 U.S. Best Managed Company, No. 3 in the 2022 CNBC Disruptor 50 list, No. 17 in the 2021 CNBC Disruptor 50 list, the No 1. Data Science company, and 23rd overall, on Fast Company’s 2019 list of The World’s Most Innovative Companies, in addition to being included on Fortune’s Change The World list in 2020. (www.lineagelogistics.com)
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221116005327/en/
Contact information
Lineage Logistics
Christina Wiese
734-608-1855
cwiese@lineagelogistics.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Altasciences Supports 4B Healthcare in Advancing Steroid Nasal Irrigation Rinse to Clinical Trials24.9.2026 15:40:00 EEST | Press release
Altasciences is proud to announce that recent formulation work supporting 4B Healthcare Inc. (“4B”) has helped advance its RhineX nasal irrigation rinse therapy into clinical investigation. Following several months of formulation development, R&D manufacturing, stability testing, and quality assurance support at Altasciences’ CDMO facility in Harleysville, PA, the Tennessee-based pharmaceutical company has received FDA clearance to proceed with clinical testing of RhineX under its IND. First subject dosing is planned for October 2026, approximately seven months after formulation development began. "The concept for RhineX grew out of a problem I have seen in my own ENT practice for years—the need for a better treatment option for allergic rhinitis when conventional medical therapy is not enough,” said Brannon Mangus, MD, Co-Founder and CEO of 4B. “We founded 4B Healthcare to take that physician insight and turn it into a pharmaceutical product that could meaningfully change how these pa
ParaScript Acquired by Stakk to Create a Global Digital Trust Platform Focused on Combating Fraud24.9.2026 15:30:00 EEST | Press release
ParaScript, an Al-powered document processing company, today announced that Stakk Limited (ASX: SKK) (“Stakk”), a company publicly traded on the Australian Stock Exchange (ASX), has successfully completed its US$63 million (A$88.7 million) acquisition of ParaScript, LLC and ParaScript Management, Inc. (“ParaScript”), creating a scaled and profitable AI-native digital trust platform. Stakk acquired ParaScript for its industry-leading AI-powered document processing and recognition technology, which uses advanced machine learning to process large volumes of documents with high speed and accuracy, helping organizations detect fraud earlier, prevent losses and improve outcomes. The combined business becomes one of the largest AI-native digital trust infrastructures serving regulated industries, with more than 300 enterprise customers and more than 110 billion digital interactions processed annually across the U.S., Europe, the Middle East and Australia. Customers include many of the world's
SLB Awarded Four Multi-Year Integrated Well Construction Contracts by Aramco24.9.2026 15:04:00 EEST | Press release
Global energy technology company SLB (NYSE: SLB) today announced it has been awarded four integrated well construction contracts by Aramco to support oil and gas development across the Kingdom of Saudi Arabia. Under the contracts, SLB will manage end-to-end well construction services, delivering more than 450 wells in the three-year term, with an optional extension of up to two years. "Delivering hundreds of wells across a multi-year program and in multiple operating environments requires an integrated model that connects planning, execution, and digital workflows to set new industry performance benchmarks,” said Steve Gassen, executive vice president of Geographies for SLB. “Awarding SLB these advanced well construction programs at scale reflects Aramco’s confidence in our integrated model and capabilities." SLB's integrated well construction model brings together every aspect of well delivery through a technology-enabled operating model. It combines digital drilling workflows with au
Sahajanand Medical Technologies Receives EU MDR Certification for Supraflex Cruz and Product Family, Reinforcing Global Compliance and Patient Safety24.9.2026 15:03:00 EEST | Press release
Sahajanand Medical Technologies Limited (SMT), a leading global manufacturer of cardiovascular medical devices, today announced that it has received certification under the European Union Medical Device Regulation (EU MDR 2017/745) for Supraflex Cruz and its product family. SMT is a leading player in India’s drug-eluting stent market and ranks among the top five companies in key European markets, including Germany, Spain and Poland. The certification follows the conformity assessment process established under EU MDR 2017/745 including assessment of SMT’s technical documentation, clinical evaluation and quality management system. Together with SMT’s existing ISO 13485 quality management system and MDSAP certifications, the EU MDR certification confirms that Supraflex Cruz has successfully undergone assessment against the EU MDR’s stringent requirements for safety, performance and clinical evidence. Supraflex Cruz is a sirolimus-eluting coronary stent system designed to improve luminal d
Acadia Pharmaceuticals Announces Phase 3 Enabling Topline Results from Phase 2 RADIANT Study of Remlifanserin for the Treatment of Alzheimer’s Disease Psychosis (ADP)24.9.2026 14:00:00 EEST | Press release
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced Phase 3 enabling topline results from the Phase 2 portion of the ongoing RADIANT clinical trial program evaluating remlifanserin for the treatment of hallucinations and delusions associated with Alzheimer’s disease psychosis (ADP). For the primary endpoint of change from baseline in the Scale for the Assessment of Positive Symptoms-Hallucinations and Delusions subscales (SAPS-H+D), once daily 60 mg remlifanserin demonstrated a change of -12.6 versus a -10.4 change for placebo at week 6, yielding a standardized effect size of 0.26 (p=0.0603). For the key secondary endpoint, Clinical Global Impression – Severity (CGI-S-ADP), the 60 mg dose achieved a change from baseline of -1.3 versus a change of -0.9 for placebo at week 6, yielding a standardized effect size of 0.37 [p=0.0077 (nominal)]. On both efficacy measures, the difference in the 60 mg dose versus placebo increased through the 6-week treatment period. The 30 mg dose showe
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
